Fewer needles, same safety? new study tests smarter prostate biopsy
NCT ID NCT07516223
First seen Apr 12, 2026 · Last updated Apr 24, 2026 · Updated 1 time
Summary
This study looks at whether men with a very high PSA level and a suspicious MRI can safely skip the extra 12 needle samples usually taken during a prostate biopsy. Currently, standard practice adds these extra samples to avoid missing cancer, but they also increase pain, bleeding, and infection risk. Researchers will compare results from 850 men to see if the targeted samples alone catch all dangerous cancers in this high-risk group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSA PROGRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.